eMolecules Newark

eMolecules is a leading chemical search-and-fulfillment platform that aims to reduce timelines in early drug discovery. Founded in 2005 and headquartered in San Diego, eMolecules provides scientists with access to over 83 million specialty chemistry and biology part numbers through its state-of-the-art digital platform. Our core offerings include: 1. A vast chemical structure database for building blocks and screening compounds 2. Integrated software for streamlined procurement 3. Compound reformatting, storage, and management services 4. Analytical chemistry and global distribution logistics 5. Synthesis of hits discovered from our multiple billion compound virtual libraries. eMolecules' platform -designed by chemists for chemists- offers real-time pricing, availability, and shipping information, and has strategic partnerships with major eProcurement and eCommerce platforms. Our mission is to accelerate drug discovery by removing inefficiencies in chemical compound sourcing. eMolecules serves pharmaceutical, biotechnology, academic, CRO, and agrochemical industries, providing essential tools and services to empower researchers in their quest for new cures and treatments. The site location in Newark (USA), is founded as Frontier Scientific Inc. in 1988, and provides chemistry and chemistry support services required in traditional small molecule drug discovery. eMolecules acquired Frontier Scientific Inc. (FSI) in September 2022.